# DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in CTO.

> **NCT02936011** · NA · UNKNOWN · sponsor: **Belfast Health and Social Care Trust** · enrollment: 50 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** CTO PCI using Absorb Bioresorbable Vascular Scaffolds

## Key facts

- **NCT ID:** NCT02936011
- **Lead sponsor:** Belfast Health and Social Care Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2018-03
- **Final completion:** 2019-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-10-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02936011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02936011, "DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in CTO.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02936011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*